Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

NCT04559893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 729

Last updated 2025-07-15

No results posted yet for this study

Summary

Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.

Conditions

Interventions

BEHAVIORAL

Collaborative Care

Collaborative care consists of a team of providers that includes a care coordinator, a primary care provider (PCP) and a behavioral health consultant (BHC), who provide evidence- and measurement-based care to a panel of patients using a clinical registry. In our model, the CC team also includes a behavioral health psychotherapist (BHP) who consults on a regular basis but does not deliver direct care.

Sponsors & Collaborators

  • University of New Mexico

    collaborator OTHER
  • Boston Medical Center

    collaborator OTHER
  • First Choice Community Healthcare

    collaborator UNKNOWN
  • Hidalgo Medical Services

    collaborator UNKNOWN
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Stanford University

    collaborator OTHER
  • University of Pittsburgh

    collaborator OTHER
  • Saint John's Cancer Institute

    collaborator OTHER
  • Olive View-UCLA Education & Research Institute

    collaborator OTHER
  • RAND

    lead OTHER

Principal Investigators

  • Katherine Watkins · RAND

  • Miriam Komaromy · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2024-06-12
Completion
2024-06-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559893 on ClinicalTrials.gov